Compare Abbott India with Lupin Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs LUPIN - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

LUPIN 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA LUPIN ABBOTT INDIA/
LUPIN
 
P/E (TTM) x 54.5 111.6 48.9% View Chart
P/BV x 13.2 2.5 519.4% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 ABBOTT INDIA   LUPIN
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
LUPIN
Mar-19
ABBOTT INDIA/
LUPIN
5-Yr Chart
Click to enlarge
High Rs8,834986 896.0%   
Low Rs5,458720 757.6%   
Sales per share (Unadj.) Rs1,731.1369.5 468.5%  
Earnings per share (Unadj.) Rs211.913.4 1,580.9%  
Cash flow per share (Unadj.) Rs219.937.4 588.2%  
Dividends per share (Unadj.) Rs65.000-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs945.2303.7 311.2%  
Shares outstanding (eoy) m21.25452.49 4.7%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x4.12.3 178.8%   
Avg P/E ratio x33.763.6 53.0%  
P/CF ratio (eoy) x32.522.8 142.4%  
Price / Book Value ratio x7.62.8 269.1%  
Dividend payout %30.70-   
Avg Mkt Cap Rs m151,848386,064 39.3%   
No. of employees `0003.517.7 19.7%   
Total wages/salary Rs m4,35631,513 13.8%   
Avg. sales/employee Rs Th10,555.59,453.8 111.7%   
Avg. wages/employee Rs Th1,249.91,782.0 70.1%   
Avg. net profit/employee Rs Th1,292.2343.0 376.7%   
INCOME DATA
Net Sales Rs m36,786167,182 22.0%  
Other income Rs m1,1333,640 31.1%   
Total revenues Rs m37,919170,822 22.2%   
Gross profit Rs m6,04728,822 21.0%  
Depreciation Rs m16910,850 1.6%   
Interest Rs m233,078 0.7%   
Profit before tax Rs m6,98918,534 37.7%   
Minority Interest Rs m0-89 0.0%   
Prior Period Items Rs m038 0.0%   
Extraordinary Inc (Exp) Rs m0-3,400 0.0%   
Tax Rs m2,4859,017 27.6%   
Profit after tax Rs m4,5036,066 74.2%  
Gross profit margin %16.417.2 95.4%  
Effective tax rate %35.648.7 73.1%   
Net profit margin %12.23.6 337.4%  
BALANCE SHEET DATA
Current assets Rs m27,610138,536 19.9%   
Current liabilities Rs m8,56961,299 14.0%   
Net working cap to sales %51.846.2 112.0%  
Current ratio x3.22.3 142.6%  
Inventory Days Days6084 71.9%  
Debtors Days Days27112 24.4%  
Net fixed assets Rs m1,057127,516 0.8%   
Share capital Rs m213905 23.5%   
"Free" reserves Rs m19,873136,517 14.6%   
Net worth Rs m20,086137,422 14.6%   
Long term debt Rs m066,417 0.0%   
Total assets Rs m29,409279,494 10.5%  
Interest coverage x311.67.0 4,438.2%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.30.6 209.1%   
Return on assets %15.43.3 470.4%  
Return on equity %22.44.4 508.0%  
Return on capital %34.98.9 391.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m36959,414 0.6%   
Fx outflow Rs m4,91822,282 22.1%   
Net fx Rs m-4,54937,132 -12.3%   
CASH FLOW
From Operations Rs m4,99116,660 30.0%  
From Investments Rs m-2,570-32,825 7.8%  
From Financial Activity Rs m-1,4287,441 -19.2%  
Net Cashflow Rs m993-8,724 -11.4%  

Share Holding

Indian Promoters % 0.0 46.6 -  
Foreign collaborators % 75.0 0.2 37,500.0%  
Indian inst/Mut Fund % 7.9 11.3 69.9%  
FIIs % 0.1 31.9 0.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 10.1 169.3%  
Shareholders   18,270 98,259 18.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   GLENMARK PHARMA  FULFORD INDIA  ORCHID PHARMA LTD  DIVIS LABORATORIES  J.B.CHEMICALS  

Compare ABBOTT INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Remains Rangebound; Bharti Airtel and ONGC Top Losers(12:30 pm)

Stock markets in India are presently trading flat. The BSE Sensex is trading down by 31 points and the NSE Nifty is trading down by 14 points.

Related Views on News

LUPIN Announces Quarterly Results (2QFY20); Net Profit Down 146.4% (Quarterly Result Update)

Nov 7, 2019 | Updated on Nov 7, 2019

For the quarter ended September 2019, LUPIN has posted a net profit of Rs 1 bn (down 146.4% YoY). Sales on the other hand came in at Rs 44 bn (up 10.3% YoY). Read on for a complete analysis of LUPIN's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

How the Modi Government is Helping My Top 7 Stocks(The 5 Minute Wrapup)

Nov 14, 2019

Recent reforms by the Modi government can give a big boost on your stocks, provided you buy the right ones.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Nov 21, 2019 03:37 PM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS